Timing
Purchase and sale flow
PurchasesSales
Stock, pipeline and biotech catalyst intelligence
Reported ownership activity
Activity signal
No open-market purchases versus $1.4M in reported salesOption exercises, awards, and grants are separated from open-market direction.Timing
Composition
Concentration
| Insider trading | Relationship | Date | Transaction | Cost | Shares | Value | Shares total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Laumas Sandeep | CFO and CBO | Sep 10 '25 | Option Exercise | $12.07 | 30,000 | $362,040 | 30,000 | Sep 12 05:00 PM |
| Laumas Sandeep | CFO and CBO | Sep 10 '25 | Sale | $23.39 | 30,000 | $701,667 | 0 | Sep 12 05:00 PM |
| Sandeep Laumas | Officer |
Company profile
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
Company profile supplied by Yahoo Finance. Catalyst dates can change and should be confirmed against the linked primary source.
Page updated Aug 21, 2026 · Yahoo quotes cached for one minute; reference data may be used when a live field is unavailable.
| Sep 10 '25 |
| Proposed Sale |
| $23.39 |
| 30,000 |
| $701,595 |
| — |
| Sep 10 05:37 PM |
Transactions may include sales, purchases, grants, and option exercises. Directional charts count only purchases and sales; follow the Form 4 link to verify the original SEC filing.